Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

A look at the long-term safety of an extended-regimen OC.

Davis MG, Reape KZ, Hait H.

J Fam Pract. 2010 May;59(5):E3.

PMID:
20544040
3.

Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.

Teichmann A, Apter D, Emerich J, Greven K, Klasa-Mazurkiewicz D, Melis GB, Spaczynski M, Grubb GS, Constantine GD, Spielmann D.

Contraception. 2009 Dec;80(6):504-11. doi: 10.1016/j.contraception.2009.05.128. Epub 2009 Aug 6.

PMID:
19913143
4.

Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.

Kaunitz AM, Portman DJ, Hait H, Reape KZ.

Contraception. 2009 May;79(5):350-5. doi: 10.1016/j.contraception.2008.11.011. Epub 2009 Jan 17.

PMID:
19341846
5.

Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.

Portman DJ, Kaunitz AM, Howard B, Weiss H, Hsieh J, Ricciotti N.

Contraception. 2014 Apr;89(4):299-306. doi: 10.1016/j.contraception.2014.01.013. Epub 2014 Jan 29.

6.

Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.

Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD.

Contraception. 2006 Dec;74(6):439-45. Epub 2006 Sep 18.

PMID:
17157099
8.

Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.

Coffee AL, Sulak PJ, Kuehl TJ.

Contraception. 2007 Jun;75(6):444-9. Epub 2007 Mar 23.

PMID:
17519150
9.

Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial.

Anderson FD, Gibbons W, Portman D.

Am J Obstet Gynecol. 2006 Jul;195(1):92-6. Epub 2006 Apr 21.

PMID:
16813747
10.

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.

Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T.

Contraception. 1999 Nov;60(5):269-74.

PMID:
10717778
11.

A new ultra-low-dose combination oral contraceptive.

Woutersz TB.

J Reprod Med. 1983 Jan;28(1 Suppl):81-4.

PMID:
6403705
13.

Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.

Stewart FH, Kaunitz AM, Laguardia KD, Karvois DL, Fisher AC, Friedman AJ.

Obstet Gynecol. 2005 Jun;105(6):1389-96.

PMID:
15932834
14.

Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.

Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Lange E, Mellinger U, Palombo-Kinne E, Kuhl H.

Contraception. 2011 Aug;84(2):133-43. doi: 10.1016/j.contraception.2011.01.002. Epub 2011 Feb 21.

PMID:
21757054
15.

Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study.

Jensen JT, Garie SG, Trummer D, Elliesen J.

Contraception. 2012 Aug;86(2):110-8. doi: 10.1016/j.contraception.2011.12.009. Epub 2012 Jan 26.

PMID:
22281416
16.

Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.

Gaspard UJ, Deville JL, Dubois M.

Curr Med Res Opin. 1983;8(6):395-404.

PMID:
6406157
17.

Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen.

Sulak PJ, Kuehl TJ, Coffee A, Willis S.

Am J Obstet Gynecol. 2006 Oct;195(4):935-41. Epub 2006 May 2.

PMID:
16647684
20.

The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol.

Kroll R, Reape KZ, Margolis M.

Contraception. 2010 Jan;81(1):41-8. doi: 10.1016/j.contraception.2009.07.003.

PMID:
20004272

Supplemental Content

Support Center